Article
Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation
2020-04-29
Abstract excerpt
<title>Abstract</title> <p><bold>Objectives: </bold>B-cell depletion by rituximab (RTX) is an effective treatment for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV). However, peripheral B cell phenotypes and the selection criteria for RTX therapy in AAV remain unclear.<bold>Methods:</bold> Phenotypic characterization of circulating B cells was performed by 8-color flow cytometric anal...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 435985a1-14c6-5085-aa96-1ad9c08102d3
- DOI
- 10.21203/rs.2.23827/v2
